Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1
2018 · Cell · 758 citations
https://doi.org/10.1016/j.cell.2018.09.055
A
Antonio Molinaro
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
102
Papers
4.4K
Citations
22
h-index
37
i10-index
Antonio Molinaro is an academic researcher from National Academy of Medicine. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Organ Transplantation Techniques and Outcomes. The author has an h-index of 22, co-authored 87 publications.
ORCID: 0000-0003-3432-2238Papers by this author
worksMicrobial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation
2020 · Cell Metabolism · 139 citations
https://doi.org/10.1016/j.cmet.2020.07.012
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
2024 · Genome Medicine · 31 citations
https://doi.org/10.1186/s13073-024-01296-6
Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression
2024 · JHEP Reports · 29 citations
https://doi.org/10.1016/j.jhepr.2023.100987
Hepatic expression of lipopolysaccharide-binding protein (Lbp) is induced by the gut microbiota through Myd88 and impairs glucose tolerance in mice independent of obesity
2020 · Molecular Metabolism · 28 citations
https://doi.org/10.1016/j.molmet.2020.100997
Why Doesn’t Primary Biliary Cholangitis Respond to Immunosuppressive Medications?
2017 · Current Hepatology Reports · 16 citations
https://doi.org/10.1007/s11901-017-0345-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat